Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Immune-mediated colitis associated with ocrelizumab: A new safety risk.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 14, 2023
Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease.
Journal: Journal of clinical gastroenterology
Published: September 15, 2015
Showing 1-2 of 2
Last Updated: 09/26/2026